Stocks · News reference
Accenture, Abivax and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Accenture Analysts Raise Price Targets as AI Fuels Multi-Year Growth Plan
Accenture analysts see AI creating new service demand, although the company's growth outlook depends on execution and sustained expansion in its core business.
Better High-Growth Software Stock for 2026: Figma vs. ServiceNow
The article compares two high-growth software companies: Figma, a rapidly expanding collaborative design platform with 41% revenue growth but significant losses, and ServiceNow, a mature enterprise workflow automation platform with consistent profitability and 20.9% revenue growth. The analyst recommends ServiceNow as the more conservative choice due to its proven profitability and stable operations, despite Figma's higher growth potential.
TD Cowen Maintains Hold on Accenture, Raises Price Target to $201
Susquehanna Maintains Neutral on Accenture, Raises Price Target to $230
Lobo Technologies Enters Agreement To Accelerate Development And Deployment Of AI-Powered Senior Care Solutions In China
Lobo subsidiaries, LOBO TOKEN OPS LTD. and LOBO (Hangzhou) Data Service Co., Ltd., have entered into a strategic cooperation agreement (the "Agreement") with Land Crest Advisory Limited (Land Crest), a Hong